Letters: Oral Immunotherapy for Peanut Allergies ‘Is More Than Worth the Risk’
Readers defend the risks of a costly new peanut-allergy treatment.
The U.S. Health-Care System Found a Way to Make Peanuts Cost $4,200
In September, James Hamblin wrote about the pharmaceutical company Aimmune, which had petitioned the FDA to approve a new oral-immunotherapy drug for peanut allergies. The treatment, which uses peanut flour to try to reprogram a patient’s immune system, is both costly and dangerous, Hamblin argued:
“Oral immunotherapy with peanuts is considered experimental, and no professional organization recommends that parents give
